Print this page    •   Back to Web version of article

International News
Mozambique Completes First HIV Vaccine Clinical Trial

March 19, 2013

Last week, "researchers at Mozambique's Polana Cancio Centre for Research and Public Health completed a trial evaluating the safety of an HIV vaccine candidate," the country's "first HIV vaccine trial," and it "is set to embark on a second, a demonstration of the country's increased HIV research capacity," PlusNews reports. The Phase I study "was conducted through the U.K. HIV Vaccine Consortium's Tanzania and Mozambique HIV Vaccine Programme (TaMoVac)," the news service writes, noting the second study of a Phase II HIV vaccine candidate also will be conducted by TaMoVac. "According to Ilesh Jani, director general of Mozambique's National Institute of Health, the studies, while small, mark important first steps towards bolstering clinical trial and research capacity for diseases such as HIV and malaria," PlusNews states, adding, "These diseases, along with malnutrition, continue to drive death rates in the country" (3/15).

Back to other news for March 2013


This information was reprinted from kff.org with permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives, and sign up for email delivery. © Henry J. Kaiser Family Foundation. All rights reserved.




This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report. You can find this article online by typing this address into your Web browser:
http://www.thebody.com/content/70971/mozambique-completes-first-hiv-vaccine-clinical-tr.html

General Disclaimer: TheBody.com is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBody.com should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.